Announcements Trials
Browse Landscape

Status

Completed 310Recruiting 145Unknown 88Terminated 88Active not recruiting 71Not yet recruiting 27Withdrawn 24Suspended 5No longer available 2Enrolling by invitation 1Available 1Approved for marketing 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Expanded_access 2

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Neoplasms 6Neoplasm Metastasis 2

Interventions

selitrectinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
No longer available × Neoplasm Metastasis × Tumor-Agnostic × Clear all
NCT03206931 2021-09-16

Expanded Access to Provide Selitrectinib for the Treatment of Cancers With a NTRK Gene Fusion

Bayer

No longer available
Tumor-Agnostic

Neoplasm Metastasis

NCT02473653 2017-08-11

Pilot Trial of HER-2/Neu Pulsed DC1 Vaccine for Patients With HER-2 Positive Metastatic Cancer

University of Pennsylvania

No longer available
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡